Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 1.528
Filtrar
1.
PLoS One ; 19(5): e0302690, 2024.
Artículo en Inglés | MEDLINE | ID: mdl-38722982

RESUMEN

BACKGROUND: Rabies virus (RABV; species Lyssavirus rabies) is causing one of the oldest zoonotic diseases known to mankind, leading to fatal encephalomyelitis in animals and humans. Despite the existence of safe and effective vaccines to prevent the disease, an estimated 99% of human rabies deaths worldwide are caused by dog-mediated rabies with children at the highest risk of infection. Rabies has been endemic in Madagascar for over a century, yet there has been little research evaluating local knowledge and practices impacting on the rabies control and prevention. Thus, this study was undertaken to better understand the dog ecology including canine vaccine coverage and to assess knowledge and practices of dog owners and veterinarians. METHODOLOGY: A cross-sectional study was conducted among 123 dog-owning households in thirteen fokontanys in Mahajanga from July 4 to September 13, 2016. Single and multi-member dog-owning households in the study area on the day of the interview were eligible for inclusion and purposively selected with the support of a local guide. The survey included a household questionnaire capturing information on the dog's demographics, husbandry practices, knowledge and practices towards rabies and its control measures; the dog ecology questionnaire collected dog characteristics, vaccination status and husbandry practices. All households that reported a dog bite incident, were invited to participate in a dog bite questionnaire. In addition, direct observations of roaming dogs were conducted to assess dog population demographics and to document behavioural characteristics. Two veterinarians were purposively selected and took part in an interview during the survey period, providing information on rabies control activities, including dog-care practices in the area. Descriptive and inferential data analyses were performed using Epi Info version 7.1.5.0 (CDC Atlanta, USA). RESULTS: We recorded a total of 400 dogs, of which 338 (84.5%) were owned amongst 123 households. More than half (67.8%) of owned dogs were between 1 to 5 years old and 95.6% were kept for guarding purposes. 45% of the surveyed dogs had free access to roam outside the premises. The majority (85.4%) of dog owners were knowledgeable that a dog bite could potentially transmit RABV to humans. 19 dog bites were reported and of these 73.6% were caused by the owner's or a neighbour's dog. In 6 of the 19 cases, children between 7 and 15 years of age were the victims. Dog vaccination coverage against rabies was 34% among owned dogs. Of the participants aware of a veterinarian, the majority (55/82) indicated that they accessed veterinarian services at irregular intervals. The main obstacles to vaccinations cited by dog owners were limited financial resources and difficulty accessing veterinary care. CONCLUSION: This study contributes to enhanced understanding of the dog ecology including canine vaccine coverage as well as knowledge and practices of dog owners in Madagascar. Most dogs in the study area were accessible for preventive vaccination through their owners, however only one third of the investigated canine population was vaccinated against rabies. Concerted national efforts towards rabies prevention and control should aim to address financial challenges and access to veterinary services.


Asunto(s)
Enfermedades de los Perros , Vacunas Antirrábicas , Rabia , Perros , Animales , Rabia/prevención & control , Rabia/veterinaria , Rabia/epidemiología , Madagascar/epidemiología , Enfermedades de los Perros/prevención & control , Enfermedades de los Perros/virología , Enfermedades de los Perros/epidemiología , Humanos , Vacunas Antirrábicas/administración & dosificación , Estudios Transversales , Masculino , Femenino , Conocimientos, Actitudes y Práctica en Salud , Encuestas y Cuestionarios , Adulto , Cobertura de Vacunación/estadística & datos numéricos , Persona de Mediana Edad , Ecología , Virus de la Rabia/inmunología
2.
PLoS Negl Trop Dis ; 18(5): e0012154, 2024 May.
Artículo en Inglés | MEDLINE | ID: mdl-38713728

RESUMEN

Rabies remains a burden in Africa, disproportionately affecting the most vulnerable despite the availability of effective vaccines. Nigeria, the most populous African country, needs rapid disease control actions and commitments to achieve the goal of eliminating dog-mediated rabies by 2030. Surveillance is an essential element of effective disease control strategies. This study examined the current state of operationality of the rabies surveillance system for early case detection and management in Gombe state, Nigeria, through a One Health lens. It further examined the barriers impeding the effectiveness of the surveillance based on the perception of surveillance workers. Qualitative and quantitative methods were used to assess the structure of the system and its functioning. Data on dog bite and rabid cases obtained from the veterinary services in Gombe state were analysed descriptively. A total of 13 key informants were interviewed using a semi-structured interview guide. Qualitative data were analysed using thematic analysis to explore in depth the factors that influenced the operationality of the system. A total of 157 potential human exposures to rabies were identified in this study, out of which two people reportedly died at the health facility after showing symptoms highly suggestive of rabies. In terms of rabies surveillance and control, cross-sectoral collaboration was found between the human health and veterinary sectors for risk assessment of potential rabies exposures and its management. Some identified factors affecting the operations of the surveillance were inadequate funding, lack of infrastructure, lack of feedback from higher authorities and insufficient knowledge of rabies prevention and management. To improve the capacity for case detection and management within the state, the appropriate authorities may focus on increasing awareness about the disease to the populace to increase the number of cases identified by the system, employ more workers and strengthen the surveillance capability of existing workers.


Asunto(s)
Rabia , Rabia/epidemiología , Rabia/prevención & control , Rabia/veterinaria , Nigeria/epidemiología , Humanos , Animales , Perros , Enfermedades de los Perros/epidemiología , Enfermedades de los Perros/prevención & control , Enfermedades de los Perros/virología , Femenino , Masculino , Adulto , Mordeduras y Picaduras/epidemiología , Persona de Mediana Edad , Monitoreo Epidemiológico , Adulto Joven , Adolescente , Salud Única
3.
Rev Med Virol ; 34(3): e2542, 2024 May.
Artículo en Inglés | MEDLINE | ID: mdl-38747622

RESUMEN

Influenza in dogs holds considerable public health significance due to their close companionship with humans, yet several facets of this phenomenon remain largely unexplored. This study undertook a systematic review and meta-analysis of observational studies to gauge the global seroprevalence of influenza in dogs. We also assessed whether pet dogs exhibited a higher seroprevalence of influenza compared to non-pet dogs, explored seasonal variations in seroprevalence, scrutinised the design and reporting standards of existing studies, and elucidated the geographical distribution of canine influenza virus (cIV). A comprehensive analysis of 97 studies spanning 27 countries revealed that seroprevalence of various influenza strains in dogs consistently registered below 10% and exhibited relative stability over the past decade. Significantly, we noted that seroprevalence of human influenza virus was notably higher in pet dogs compared to their non-pet counterparts, whereas seroprevalence of other influenza strains remained relatively uniform among both categories of dogs. Seasonal variations in seroprevalence of cIV were not observed. In summary, our findings indicated the global circulation of cIV strains H3N2 and H3N8, with other strains primarily confined to China. Given the lack of reported cases of the transmission of cIV from dogs to humans, our findings suggest a higher risk of reverse zoonosis than zoonosis. Finally, we strongly advocate for standardised reporting guidelines to underpin future canine influenza research endeavours.


Asunto(s)
Enfermedades de los Perros , Infecciones por Orthomyxoviridae , Animales , Perros , Humanos , Enfermedades de los Perros/epidemiología , Enfermedades de los Perros/virología , Salud Global , Virus de la Influenza A/inmunología , Virus de la Influenza A/aislamiento & purificación , Subtipo H3N2 del Virus de la Influenza A/inmunología , Subtipo H3N2 del Virus de la Influenza A/aislamiento & purificación , Infecciones por Orthomyxoviridae/epidemiología , Infecciones por Orthomyxoviridae/veterinaria , Infecciones por Orthomyxoviridae/virología , Infecciones por Orthomyxoviridae/inmunología , Prevalencia , Estaciones del Año , Estudios Seroepidemiológicos
4.
Artículo en Alemán | MEDLINE | ID: mdl-38701805

RESUMEN

For detection of infectious diseases, several point-of-care (POC) tests are on the market in addition to methods performed in commercial laboratories. These POC tests are based on enzyme-linked immunosorbent assay (ELISA) or other immunochromatographic technologies and present results within few minutes in veterinary practice. This article gives an overview of the utility of numerous POC tests of different manufacturers for detection of parvovirus antigen in feces, Dirofilaria (D.) immitis antigen in blood as well as antibodies against Borrelia (B.) burgdorferi, Anaplasma (A.) spp., Ehrlichia (E.) spp., Leptospira (L.) spp. and Leishmania (L.) infantum in blood (single or in different combinations). Sensitivity and specificity of these tests are important for their usefulness in veterinary practice. Furthermore, presence of antibodies or detection of antigen has to correlate with the presence of clinical signs. POC tests for detection of canine parvovirus antigen have a very high specificity, the sensitivity of all evaluated POC tests, however, is very low. POC tests for detection of D. immitis antigen have a very high sensitivity and specificity. As they detect antigen from the uterus of female adult parasites, test results are negative when only very few female or only male adults are present. POC tests for detection of antibodies against B. burgdorferi only indicate contact with Borrelia spp. and do not prove clinical Lyme disease, as the infection only extremely rarely causes clinical signs. POC tests for detection of antibodies against A. phagocytophilum are also not suitable for diagnosis of clinical anaplasmosis. Infections with A. phagocytophilum only lead to clinical disease in very rare cases and in these, clinical signs occur before the development of antibodies. POC tests for detection of antibodies against E. canis have a very high sensitivity as well as specificity. POC tests for detection of antibodies against L. infantum and Leptospira species (spp.) show a very high specificity and a high sensitivity. However, Leptospira spp. antibody-positive results may occur following vaccination, as the POC tests cannot distinguish between field and vaccination strains.


Asunto(s)
Enfermedades de los Perros , Enfermedades de los Perros/diagnóstico , Enfermedades de los Perros/microbiología , Enfermedades de los Perros/virología , Animales , Perros , Sensibilidad y Especificidad , Sistemas de Atención de Punto , Ensayo de Inmunoadsorción Enzimática/veterinaria , Ensayo de Inmunoadsorción Enzimática/métodos
5.
Vet Microbiol ; 293: 110098, 2024 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-38677126

RESUMEN

The infection of canine coronavirus (CCoV) causes a highly contagious disease in dogs with acute gastroenteritis. The efficient serological diagnostics is critical for controlling the disease caused by CCoV. Nucleocapsid (N) protein of CCoV is an important target for developing serological approaches. However, little is known about the antigenic sites in the N protein of CCoV. In this study, we generated a monoclonal antibody (mAb) against the N protein of CCoV, designated as 13E8, through the fusion of the sp2/0 cells with the spleen cells from a mouse immunized with the purified recombinant GST-N protein. Epitope mapping revealed that mAb 13E8 recognized a novel linear B cell epitope in N protein at 294-314aa (named as EP-13E8) by using a serial of truncated N protein through Western blot and ELISA. Sequence analysis showed that the sequence of EP-13E8 was highly conserved (100 %) among different CCoV strains analyzed, but exhibited a low similarity (31.8-63.6 %) with the responding sequence in other coronaviruses of the same genus such as FCoV, PEDV and HCoV except for TGEV (95.5 % identity). Structural assay suggested that the epitope of EP-13E8 were located in the close proximity on the surface of the N protein. Overall, the mAb 13E8 against N protein generated and its epitope EP-13E8 identified here paid the way for further developing epitope-based serological diagnostics for CCoV.


Asunto(s)
Anticuerpos Monoclonales , Coronavirus Canino , Mapeo Epitopo , Epítopos de Linfocito B , Proteínas de la Nucleocápside , Animales , Anticuerpos Monoclonales/inmunología , Epítopos de Linfocito B/inmunología , Perros , Ratones , Proteínas de la Nucleocápside/inmunología , Coronavirus Canino/inmunología , Anticuerpos Antivirales/inmunología , Anticuerpos Antivirales/sangre , Ratones Endogámicos BALB C , Proteínas de la Nucleocápside de Coronavirus/inmunología , Enfermedades de los Perros/virología , Enfermedades de los Perros/inmunología , Infecciones por Coronavirus/veterinaria , Infecciones por Coronavirus/inmunología , Infecciones por Coronavirus/virología , Infecciones por Coronavirus/diagnóstico , Secuencia de Aminoácidos
6.
N Z Vet J ; 72(4): 191-200, 2024 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-38650102

RESUMEN

AIMS: To isolate canine respiratory coronavirus (CRCoV) and canine pneumovirus (CnPnV) in cell culture and to compare partial genomic sequences of CRCoV and CnPnV from New Zealand with those from other countries. METHODS: Oropharyngeal swab samples from dogs affected by canine infectious respiratory disease syndrome that were positive for CnPnV (n = 15) or CRCoV (n = 1) by virus-specific reverse transcriptase quantitative PCR (RT-qPCR) in a previous study comprised the starting material. Virus isolation was performed in HRT-18 cells for CRCoV and RAW 264.7 and Vero cells for CnPnV. The entire sequence of CnPnV G protein (1,266 nucleotides) and most (8,063/9,707 nucleotides) of the 3' region of CRCoV that codes for 10 structural and accessory proteins were amplified and sequenced. The sequences were analysed and compared with other sequences available in GenBank using standard molecular tools including phylogenetic analysis. RESULTS: Virus isolation was unsuccessful for both CRCoV and CnPnV. Pneumovirus G protein was amplified from 3/15 (20%) samples that were positive for CnPnV RNA by RT-qPCR. Two of these (NZ-048 and NZ-049) were 100% identical to each other, and 90.9% identical to the third one (NZ-007). Based on phylogenetic analysis of the G protein gene, CnPnV NZ-048 and NZ-049 clustered with sequences from the USA, Thailand and Italy in group A, and CnPnV NZ-007 clustered with sequences from the USA in group B. The characteristics of the predicted genes (length, position) and their putative protein products (size, predicted structure, presence of N- and O-glycosylation sites) of the New Zealand CRCoV sequence were consistent with those reported previously, except for the region located between open reading frame (ORF)3 (coding for S protein) and ORF6 (coding for E protein). The New Zealand virus was predicted to encode 5.9 kDa, 27 kDa and 12.7 kDa proteins, which differed from the putative coding capacity of this region reported for CRCoV from other countries. CONCLUSIONS: This report represents the first characterisation of partial genomic sequences of CRCoV and CnPnV from New Zealand. Our results suggest that the population of CnPnV circulating in New Zealand is not homogeneous, and that the viruses from two clades described overseas are also present here. Limited conclusions can be made based on only one CRCoV sequence, but the putative differences in the coding capacity of New Zealand CRCoV support the previously reported variability of this region. The reasons for such variability and its biological implications need to be further elucidated.


Asunto(s)
Coronavirus Canino , Enfermedades de los Perros , Genoma Viral , Filogenia , Pneumovirus , Animales , Perros , Nueva Zelanda/epidemiología , Coronavirus Canino/genética , Coronavirus Canino/clasificación , Coronavirus Canino/aislamiento & purificación , Enfermedades de los Perros/virología , Enfermedades de los Perros/epidemiología , Pneumovirus/genética , Pneumovirus/clasificación , Infecciones por Coronavirus/veterinaria , Infecciones por Coronavirus/virología , Infecciones por Coronavirus/epidemiología , Células Vero , Chlorocebus aethiops
8.
PLoS Negl Trop Dis ; 18(4): e0012089, 2024 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-38635851

RESUMEN

Rabies control remains challenging in low and middle-income countries, mostly due to lack of financial resources, rapid turnover of dog populations and poor accessibility to dogs. Rabies is endemic in Cambodia, where no national rabies vaccination program is implemented. The objective of this study was to assess the short and long-term vaccination-induced immunity in Cambodian dogs under field conditions, and to propose optimized vaccination strategies. A cohort of 351 dogs was followed at regular time points following primary vaccination only (PV) or PV plus single booster (BV). Fluorescent antibody virus neutralization test (FAVNT) was implemented to determine the neutralizing antibody titer against rabies and an individual titer ≥0·5 IU/mL indicated protection. Bayesian modeling was used to evaluate the individual duration of protection against rabies and the efficacy of two different vaccination strategies. Overall, 61% of dogs had a protective immunity one year after PV. In dogs receiving a BV, this protective immunity remained for up to one year after the BV in 95% of dogs. According to the best Bayesian model, a PV conferred a protective immunity in 82% of dogs (95% CI: 75-91%) for a mean duration of 4.7 years, and BV induced a lifelong protective immunity. Annual PV of dogs less than one year old and systematic BV solely of dogs vaccinated the year before would allow to achieve the 70% World Health Organization recommended threshold to control rabies circulation in a dog population in three to five years of implementation depending on dog population dynamics. This vaccination strategy would save up to about a third of vaccine doses, reducing cost and time efforts of mass dog vaccination campaigns. These results can contribute to optimize rabies control measures in Cambodia moving towards the global goal of ending human death from dog-mediated rabies by 2030.


Asunto(s)
Anticuerpos Antivirales , Teorema de Bayes , Enfermedades de los Perros , Vacunas Antirrábicas , Rabia , Vacunación , Perros , Animales , Rabia/prevención & control , Rabia/veterinaria , Rabia/inmunología , Rabia/epidemiología , Cambodia/epidemiología , Vacunas Antirrábicas/inmunología , Vacunas Antirrábicas/administración & dosificación , Enfermedades de los Perros/prevención & control , Enfermedades de los Perros/inmunología , Enfermedades de los Perros/virología , Enfermedades de los Perros/epidemiología , Anticuerpos Antivirales/sangre , Vacunación/veterinaria , Masculino , Femenino , Anticuerpos Neutralizantes/sangre , Virus de la Rabia/inmunología
9.
Viruses ; 16(4)2024 04 12.
Artículo en Inglés | MEDLINE | ID: mdl-38675936

RESUMEN

Domestic dogs are currently recognized as being infected by 25 different canine papillomavirus (CPV) types classified into three genera. A short sequence from a novel CPV type was amplified, along with CPV1, from a papilloma (wart) from the mouth of a dog. The entire 7499 bp genome was amplified, and CPV26 contained putative coding regions that were predicted to produce four early proteins and two late ones. The ORF L1 showed less than 62% similarity for all previously sequenced CPV types but over 69% similarity to multiple Omegapapillomavirus types from a variety of Caniform species including the giant panda, Weddel seal, and polar bear. Phylogenetic analysis confirmed CPV26 clusters within the Omegapapillomavirus genus. Specific primers were used to investigate the presence of CPV26 DNA within a series of 37 canine proliferative lesions. CPV26 DNA was amplified from one lesion, a cutaneous papilloma that also contained CPV6. This is the first time a PV type within the Omegapapillomavirus genus has been detected in a non-domestic species and this provides evidence that the omegapapillomaviruses infected a common ancestor of, and then co-evolved with, the Caniform species. Whether CPV26 causes disease is uncertain, but the absence of an E7 protein may suggest low pathogenicity.


Asunto(s)
ADN Viral , Enfermedades de los Perros , Genoma Viral , Papillomaviridae , Infecciones por Papillomavirus , Filogenia , Animales , Perros , Infecciones por Papillomavirus/virología , Infecciones por Papillomavirus/veterinaria , Papillomaviridae/genética , Papillomaviridae/clasificación , Enfermedades de los Perros/virología , ADN Viral/genética , Sistemas de Lectura Abierta , Análisis de Secuencia de ADN
10.
Viruses ; 16(4)2024 04 16.
Artículo en Inglés | MEDLINE | ID: mdl-38675958

RESUMEN

Reverse zoonotic transmission events of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have been described since the start of the pandemic, and the World Organisation for Animal Health (WOAH) designated the detection of SARS-CoV-2 in animals a reportable disease. Eighteen domestic and zoo animals in Great Britain and Jersey were tested by APHA for SARS-CoV-2 during 2020-2023. One domestic cat (Felis catus), three domestic dogs (Canis lupus familiaris), and three Amur tigers (Panthera tigris altaica) from a zoo were confirmed positive during 2020-2021 and reported to the WOAH. All seven positive animals were linked with known SARS-CoV-2 positive human contacts. Characterisation of the SARS-CoV-2 variants by genome sequencing indicated that the cat was infected with an early SARS-CoV-2 lineage. The three dogs and three tigers were infected with the SARS-CoV-2 Delta variant of concern (B.1.617.2). The role of non-human species in the onward transmission and emergence of new variants of SARS-CoV-2 remain poorly defined. Continued surveillance of SARS-CoV-2 in relevant domestic and captive animal species with high levels of human contact is important to monitor transmission at the human-animal interface and to assess their role as potential animal reservoirs.


Asunto(s)
Animales de Zoológico , COVID-19 , SARS-CoV-2 , Tigres , Animales , Perros , SARS-CoV-2/genética , SARS-CoV-2/aislamiento & purificación , SARS-CoV-2/clasificación , COVID-19/transmisión , COVID-19/epidemiología , COVID-19/veterinaria , COVID-19/virología , Tigres/virología , Gatos , Animales de Zoológico/virología , Inglaterra/epidemiología , Humanos , Filogenia , Enfermedades de los Perros/virología , Enfermedades de los Perros/epidemiología , Enfermedades de los Perros/transmisión , Zoonosis/virología , Zoonosis/transmisión , Zoonosis/epidemiología
11.
Virology ; 595: 110041, 2024 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-38555807

RESUMEN

Canine parvovirus (CPV) is the main cause of viral diarrhea in dogs. CPV became a global disease in 1978 and was endemic all over the world. CPV-2 was the first strain to be identified, but with genetic mutations, new genotypes such as CPV-2a/2b/2c/new-2a/new-2b have emerged. In this study, 128 fecal samples of stray dogs suspected of CPV-2 infection were collected from January to March 2021 in Shanghai, China. All samples were screened by PCR and further analyzed by VP2 gene. The positive rate of CPV-2 was 9.4% (12/128), of which 6 CPV-2 isolates were successfully isolated. Phylogenetic tree analysis showed that 4 isolates were CPV-2c genotype and 2 were new-CPV-2b genotype. VP-2 is a key protein that determines the antigenic properties, host range and receptor binding of cpv-2. The results of VP2 amino acid sequence analysis in this study showed that the CPV-2c isolated strain was the same as the previous strains reported in China, including F267Y, Y324I, Q370R and A5G mutations in addition to the typical N426E mutations. Similarly, in addition to the conventional N426D, S297A, F267Y and Y324I mutations, the new CPV-2b isolate also had a new mutation of T440A. This study further confirmed the prevalence of CPV-2c and new-CPV-2b in Shanghai, and also found a new mutation site of new-CPV-2c, which provided a theoretical basis for further enriching the epidemiological data of CPV-2 in Shanghai, as well as the development of vaccines and the prevention and control of the disease.


Asunto(s)
Proteínas de la Cápside , Enfermedades de los Perros , Heces , Genotipo , Infecciones por Parvoviridae , Parvovirus Canino , Filogenia , Animales , Parvovirus Canino/genética , Parvovirus Canino/aislamiento & purificación , Parvovirus Canino/clasificación , Perros , China/epidemiología , Infecciones por Parvoviridae/veterinaria , Infecciones por Parvoviridae/virología , Infecciones por Parvoviridae/epidemiología , Enfermedades de los Perros/virología , Enfermedades de los Perros/epidemiología , Heces/virología , Proteínas de la Cápside/genética , Mutación
12.
J Virol ; 98(3): e0169523, 2024 Mar 19.
Artículo en Inglés | MEDLINE | ID: mdl-38349085

RESUMEN

Histone modifications function in both cellular and viral gene expression. However, the roles of acetyltransferases and histone acetylation in parvoviral infection remain poorly understood. In the current study, we found the histone deacetylase (HDAC) inhibitor, trichostatin A (TSA), promoted the replication and transcription of parvovirus minute virus of canines (MVC). Notably, the expression of host acetyltransferases KAT5, GTF3C4, and KAT2A was increased in MVC infection, as well as H4 acetylation (H4K12ac). KAT5 is not only responsible for H4K12ac but also crucial for viral replication and transcription. The viral nonstructural protein NS1 interacted with KAT5 and enhanced its expression. Further study showed that Y44 in KAT5, which may be tyrosine-phosphorylated, is indispensable for NS1-mediated enhancement of KAT5 and efficient MVC replication. The data demonstrated that NS1 interacted with KAT5, which resulted in an enhanced H4K12ac level to promote viral replication and transcription, implying the epigenetic addition of H4K12ac in viral chromatin-like structure by KAT5 is vital for MVC replication.IMPORTANCEParvoviral genomes are chromatinized with host histones. Therefore, histone acetylation and related acetyltransferases are required for the virus to modify histones and open densely packed chromatin structures. This study illustrated that histone acetylation status is important for MVC replication and transcription and revealed a novel mechanism that the viral nonstructural protein NS1 hijacks the host acetyltransferase KAT5 to enhance histone acetylation of H4K12ac, which relies on a potential tyrosine phosphorylation site, Y44 in KAT5. Other parvoviruses share a similar genome organization and coding potential and may adapt a similar strategy for efficient viral replication and transcription.


Asunto(s)
Lisina Acetiltransferasa 5 , Infecciones por Parvoviridae , Animales , Perros , Acetilación , Acetiltransferasas/metabolismo , Cromatina , Histona Acetiltransferasas/genética , Histona Acetiltransferasas/metabolismo , Histonas/genética , Histonas/metabolismo , Infecciones por Parvoviridae/metabolismo , Infecciones por Parvoviridae/veterinaria , Infecciones por Parvoviridae/virología , Tirosina/metabolismo , Proteínas no Estructurales Virales/genética , Proteínas no Estructurales Virales/metabolismo , Línea Celular , Enfermedades de los Perros/metabolismo , Enfermedades de los Perros/virología , Lisina Acetiltransferasa 5/metabolismo
13.
Zoonoses Public Health ; 71(4): 402-415, 2024 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-38317287

RESUMEN

AIMS: Lyssavirus rabies (RABV) is responsible for a major zoonotic infection that is almost always lethal once clinical signs appear. Rabies can be (re)introduced into rabies-free areas through transboundary dog movements, thus compromising animal and human health. A number of measures have been implemented to prevent this happening, one of which is the waiting period (WP) after anti-rabies vaccination and serological testing. This WP ensures that antibodies assessed through the serological test are due to the vaccine, not to infection. Indeed, if antibodies are due to RABV infection, the dog should display clinical signs within this WP and would not therefore be imported. METHODS AND RESULTS: Within a framework of quantitative risk assessment, we used modelling approaches to evaluate the impact of this WP and its duration on the risk of introducing rabies via the importation of dogs into the European Union. Two types of models were used, a classical stochastic scenario tree model and an individual-based model, both parameterised using scientific literature or data specifically applicable to the EU. Results showed that, assuming perfect compliance, the current 3-month waiting period was associated with a median annual number of 0.04 infected dogs imported into the EU. When the WP was reduced, the risk increased. For example, for a 1-month WP, the median annual number of infected dogs imported was 0.17 or 0.15 depending on the model, which corresponds to a four-fold increase. CONCLUSION: This in silico study, particularly suitable for evaluating rare events such as rabies infections in rabies-free areas, provided results that can directly inform policymakers in order to adapt regulations linked to rabies and animal movements.


Asunto(s)
Enfermedades de los Perros , Unión Europea , Vacunas Antirrábicas , Rabia , Animales , Rabia/veterinaria , Rabia/prevención & control , Rabia/epidemiología , Perros , Enfermedades de los Perros/prevención & control , Enfermedades de los Perros/virología , Enfermedades de los Perros/transmisión , Enfermedades de los Perros/epidemiología , Vacunas Antirrábicas/administración & dosificación , Vacunas Antirrábicas/inmunología , Medición de Riesgo , Humanos , Factores de Tiempo , Virus de la Rabia/inmunología , Zoonosis
14.
Microbiol Spectr ; 11(6): e0267623, 2023 Dec 12.
Artículo en Inglés | MEDLINE | ID: mdl-37943512

RESUMEN

IMPORTANCE: Spike-receptor interaction is a critical determinant for the host range of coronaviruses. In this study, we investigated the SARS-CoV-2 WHU01 strain and five WHO-designated SARS-CoV-2 variants of concern (VOCs), including Alpha, Beta, Gamma, Delta, and the early Omicron variant, for their Spike interactions with ACE2 proteins of 18 animal species. First, the receptor-binding domains (RBDs) of Alpha, Beta, Gamma, and Omicron were found to display progressive gain of affinity to mouse ACE2. More interestingly, these RBDs were also found with progressive loss of affinities to multiple ACE2 orthologs. The Omicron RBD showed decreased or complete loss of affinity to eight tested animal ACE2 orthologs, including that of some livestock animals (horse, donkey, and pig), pet animals (dog and cat), and wild animals (pangolin, American pika, and Rhinolophus sinicus bat). These findings shed light on potential host range shift of SARS-CoV-2 VOCs, especially that of the Omicron variant.


Asunto(s)
Enzima Convertidora de Angiotensina 2 , COVID-19 , Enfermedades de los Gatos , Quirópteros , Enfermedades de los Perros , SARS-CoV-2 , Glicoproteína de la Espiga del Coronavirus , Animales , Gatos , Perros , Ratones , Enzima Convertidora de Angiotensina 2/metabolismo , Animales Salvajes/virología , Enfermedades de los Gatos/virología , Quirópteros/virología , COVID-19/metabolismo , Enfermedades de los Perros/virología , Caballos/virología , Mutación , Unión Proteica , SARS-CoV-2/genética , SARS-CoV-2/metabolismo , Porcinos/virología , Glicoproteína de la Espiga del Coronavirus/genética
15.
N Z Vet J ; 71(6): 283-294, 2023 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-37621178

RESUMEN

The introduction and subsequent rapid spread of Japanese encephalitis virus genotype IV across all Australian mainland states and the Northern Territory since late 2021 has increased the risk of an incursion of this mosquito-transmitted zoonotic virus disease into New Zealand, with serious implications for both animal and human health. The potential modes of entry are through introduction of infected mosquitoes as hitchhikers on ships or aircraft, windborne transfer of mosquitoes, or arrival of infected reservoir bird species. A competent vector mosquito, Culex quinquefasciatus, is endemic in New Zealand and other mosquito species may also become involved. If infection becomes established in New Zealand, the scale of transmission may be considerably less than has occurred in Australia because climatic and epidemiological factors are not so favourable. Early evidence of an incursion could come from detection of clinical disease in horses or pigs, or from human cases. Targeted surveillance to confirm or refute indications of an incursion could be undertaken by antibody detection in a number of species. Dogs have been shown to be a particularly valuable sentinel species due to their cohabitation with people and high seroconversion rate. Other novel methods of surveillance could include reverse transcriptase PCR (RT-PCR) on oronasal secretions of pigs. Should evidence of the disease be detected, prompt action would be required to vaccinate at-risk human populations and clarify the epidemiological situation with respect to mammalian hosts and mosquito vector species, including whether a new mosquito species had arrived in the country.Abbreviations: AHL: Animal Health Laboratory; JE: Japanese encephalitis disease; JEV: Japanese encephalitis virus; RT-PCR: Reverse transcriptase PCR.


Asunto(s)
Enfermedades de los Perros , Virus de la Encefalitis Japonesa (Especie) , Enfermedades de los Caballos , Enfermedades de los Porcinos , Animales , Perros , Humanos , Australia/epidemiología , Enfermedades de los Perros/virología , Virus de la Encefalitis Japonesa (Especie)/genética , Enfermedades de los Caballos/virología , Caballos , Nueva Zelanda/epidemiología , ARN Viral/análisis , Sensibilidad y Especificidad , Porcinos , Enfermedades de los Porcinos/virología , Zoonosis/epidemiología
18.
BMC Vet Res ; 19(1): 60, 2023 Mar 15.
Artículo en Inglés | MEDLINE | ID: mdl-36922800

RESUMEN

BACKGROUND: Canine distemper virus (CDV) is one of the most contagious and lethal viruses known to the Canidae, with a very broad and expanding host range. Autophagy serves as a fundamental stabilizing response against pathogens, but some viruses have been able to evade or exploit it for their replication. However, the effect of autophagy mechanisms on CDV infection is still unclear. RESULTS: In the present study, autophagy was induced in CDV-infected Vero cells as demonstrated by elevated LC3-II levels and aggregation of green fluorescent protein (GFP)-LC3 spots. Furthermore, CDV promoted the complete autophagic process, which could be determined by the degradation of p62, co-localization of LC3 with lysosomes, GFP degradation, and accumulation of LC3-II and p62 due to the lysosomal protease inhibitor E64d. In addition, the use of Rapamycin to promote autophagy promoted CDV replication, and the inhibition of autophagy by Wortmannin, Chloroquine and siRNA-ATG5 inhibited CDV replication, revealing that CDV-induced autophagy facilitated virus replication. We also found that UV-inactivated CDV still induced autophagy, and that nucleocapsid (N) protein was able to induce complete autophagy in an mTOR-dependent manner. CONCLUSIONS: This study for the first time revealed that CDV N protein induced complete autophagy to facilitate viral replication.


Asunto(s)
Virus del Moquillo Canino , Moquillo , Enfermedades de los Perros , Proteínas de la Nucleocápside , Replicación Viral , Animales , Perros , Autofagia , Chlorocebus aethiops , Virus del Moquillo Canino/fisiología , Enfermedades de los Perros/virología , Células Vero , Proteínas de la Nucleocápside/metabolismo
19.
Artículo en Alemán | MEDLINE | ID: mdl-36323272

RESUMEN

Although vaccines against canine parvovirus (CPV) are used worldwide, CPV infection still occurs relatively commonly, mainly in young dogs. This review article focuses on different causes of vaccination failures. Various factors affecting the dog itself or its environment can be responsible. A subset of dogs fail to develop antibodies (non-responders) or produce only very low antibody titers (low-responders) following vaccination against CPV for genetic reasons. In addition, vaccination efficacy can be affected by other intrinsic factors (e. g., weight, age, reproductive, and nutritional status, diseases) and/or extrinsic factors (e. g., stress, physical strain, medications). In addition to these causes affecting the individual dog, vaccine failure can also be caused by reduced immunizing properties of the vaccine itself. A variety of different factors (e. g., manufacturing, storage, application) can be responsible for this effect.


Asunto(s)
Enfermedades de los Perros , Infecciones por Parvoviridae , Parvovirus Canino , Vacunas Virales , Animales , Perros , Anticuerpos Antivirales , Enfermedades de los Perros/prevención & control , Enfermedades de los Perros/virología , Infecciones por Parvoviridae/prevención & control , Infecciones por Parvoviridae/veterinaria , Vacunación/veterinaria , Insuficiencia del Tratamiento
20.
Vet Res Commun ; 46(4): 1291-1295, 2022 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-35916969

RESUMEN

Members of the family Parvoviridae are well recognized infectious agents of companion, livestock and wild animals as well, whose relevance on production, health, welfare and conservation is often high. Nevertheless, the knowledge of their epidemiology in wild populations is scarce or fragmentary. In this study, the presence and features of two parvoviruses, Carnivore protoparvovirus 1 and Amdoparvovirus, were evaluated in the red fox population resident in the Dolomites area, Northern Italy, and compared with the scenario of other countries and Italian regions. Six out of 117 spleen samples (5.13%: 95CI: 1.91-10.83%) tested positive to Carnivore protoparvovirus 1 and were molecularly characterized as Canine parvovirus (CPV). Infection frequency was comparable with that observed in wild carnivore populations present in Southern Italian regions, although in that case, Feline parvovirus (FPV) was predominant. No evidence of infection-related clinical signs was reported and viral loads were invariably low, suggesting the subclinical nature of the infection, the persistent carrier status or the detection of traces of viral DNA. No samples tested positive to Amdoparvovirus genus-specific PCR. The present study provides the first evidence of CPV circulation in the Northern Italy fox population. Unfortunately, the inevitable convenience nature of the sampling prevents definitive conclusions. Therefore, a more coordinated and standardized approach should be applied, at least in neighbouring geographic areas, to study these viral infections and their relevance in wildlife.


Asunto(s)
Infecciones por Parvoviridae , Parvovirus , Animales , Gatos , Perros , Animales Salvajes/virología , Enfermedades de los Gatos/virología , Enfermedades de los Perros/virología , Zorros/virología , Infecciones por Parvoviridae/epidemiología , Infecciones por Parvoviridae/veterinaria , Parvovirus/genética , Parvovirus Canino/genética
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...